SynthesisCurrent oncology (Toronto, Ont.)2020

The risk of diarrhea and colitis in patients with lung cancer treated with immune checkpoint inhibitors: a systematic review and meta-analysis.

K Bishay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.